Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada.
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS).
Clinical proteomics of enervated neurons.
PML in a patient treated with fumaric acid.
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome.
Daclizumab in multiple sclerosis: a high-yield extension study.
CHMP determines dimethyl fumarate in TECFIDERA® to be a new active substance in the European Union
Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis.
Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A₂ in Mice.
Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
Flupirtine as Oral Treatment in Multiple Sclerosis (FLORIMS)
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
Biomarkers of disease activity in multiple sclerosis.
Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Treatment with retinoid X receptor agonist IRX4204 ameliorates experimental autoimmune encephalomyelitis.
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
Dimethyl Fumarate Protects Brain From Damage Produced by Intracerebral Hemorrhage by Mechanism Involving Nrf2.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
Bioengineered cell culture systems of central nervous system injury and disease.
Neurological involvement in Primary Sjögren Syndrome.
Opinion: Focus on preclinical sex differences will not address women's and men's health disparities.
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study.
The cell biology of CNS myelination.
Central fatigue in multiple sclerosis: a review of the literature.

Pages